港股異動 | 信義光能(00968.HK)續升6% 績後連漲3日 獲多家機構唱好
格隆匯3月9日丨信義光能(0968.HK)續升6%,3日連漲11%。現報14.05港元,暫成交3.46億港元,總市值1246億港元。公司日前公佈,2021財年全年淨利49.24億港元,同比增長7.97%。興業證券點評稱,公司業績穩健增長,產能擴張計劃飽滿。維持"買入"評級,目標價14.17港元;中金指出,公司2021業績基本符合該行預期,維持“跑贏行業”評級,目標價19.1港元;國泰君安維持其“買入”評級,目標價17.6港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.